Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?

Area of Science:

• Oncology
• Genetics
• Nephrology

Background:

• Tuberous sclerosis complex (TSC) and von Hippel-Lindau (VHL) disease are distinct autosomal dominant tumor suppressor syndromes.
• Both conditions can present with similar renal phenotypes, suggesting shared underlying mechanisms.
• Existing clinical management and emerging therapeutic strategies show overlap between TSC and VHL disease.

Purpose of the Study:

• To summarize the pathophysiologic similarities between TSC and VHL disease.
• To review the therapeutic overlap and shared signaling pathway components.
• To highlight recent drug trial results for TSC and VHL disease.

Main Methods:

• Review of existing literature on tuberous sclerosis complex and von Hippel-Lindau disease.
• Analysis of shared pathophysiologic mechanisms and signaling pathways.
• Summary of clinical management strategies and outcomes of recent drug trials.

Main Results:

• Identified significant overlap in renal phenotypes and signaling pathways between TSC and VHL disease.
• Recent drug trials show promising therapeutic approaches targeting shared pathways.
• Clinical management strategies are increasingly converging for these distinct syndromes.

Conclusions:

• TSC and VHL disease, while distinct, share critical pathophysiologic and therapeutic aspects, particularly concerning renal manifestations.
• Targeting common signaling pathways offers a promising avenue for novel therapeutic interventions in both conditions.
• Continued research and clinical trials are essential to optimize management and develop effective treatments for these tumor suppressor syndromes.